Delivery Order SPE2DB22D2103-SPE2DB25FR9UH
Award Date 9/11/25
Potential Completion Date 10/2/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a ceiling value of $5,704.45. This firm fixed-price delivery order is scheduled for completion by August 22, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Bosulif 500 mg tablets (30-count units) under a firm fixed-price contract. The order carries a ceiling value of $11,301.40 and is scheduled for completion by September 25, 2025. This is a competitively awarded, non-set-aside delivery order with performance directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents...
- The Defense Logistics Agency awarded a delivery order valued at $70,893.78 to AmerisourceBergen Drug Corp for 30-tablet supplies of Bosulif 400 mg, a pharmaceutical product used in oncology treatment. This non-competitive, firm fixed-price delivery order was awarded on September 4, 2025, with a completion date of September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child purchase order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23,631.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Bosulif 400 mg tablets (30-count units). The contract, which has no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract, utilizing no set-aside designation, represents a competitive award under the company's broader pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a contract ceiling value of $5,704.45. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The delivery order carries an ultimate completion date of October 2, 2025, and will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BOSULIF 100 mg tablets (120-count supply) on September 4, 2025, with a ceiling value of $17,113.35. This firm fixed-price contract represents a non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. BOSULIF is a prescription medication used in oncology treatment, reflecting the...
- This delivery order, awarded July 28, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 120 tablets of Bosulif 100 mg with a ceiling value of $5,704.45 and a firm fixed price structure. The order is scheduled for completion by August 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under a larger indefinite delivery contract vehicle that...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,047.42, is to deliver 120 units of the prescription drug BOSULIF 100 mg tablets. The award has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- The Defense Logistics Agency awarded a delivery order valued at $5.7K to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a tyrosine kinase inhibitor used in oncology treatment. The contract was competitively awarded without set-aside provisions under firm fixed pricing terms, with performance at the vendor's Conshohocken, Pennsylvania location and an ultimate completion date of August 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...